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Human immunodeficiency virus type 1 DNA synthesis was followed in a CD4+ line of T cells (C8166) grown
in the presence or absence of a monoclonal antibody to CD4 that blocks infection. By 48 h after infection,
cultures grown in the presence of the antibody contained -4 copies of human immunodeficiency virus type 1
DNA per cell, whereas those grown in the absence of the antibody contained -80 copies of viral DNA per cell.
Most of the viral DNA in cultures grown in the absence of the antibody was present in a broad smear of
apparently incomplete viral sequences. In cultures grown in the presence or absence of the antibody, the
9.6-kilobase linear duplex of viral DNA appeared to undergo integration within 24 h of its appearance. These
results demonstrate that T cells accumulate unintegrated human immunodeficiency virus type 1 DNA as a
result of multiple virions entering cells.
Reverse transcription of virion RNA to a duplex linear
DNA and the integration of this linear duplex into chromo-
somal DNA to form a provirus are early steps in the life
cycle of retroviruses (2, 7, 29; for a review, see reference
37). In most type C virus-infected fibroblasts, the synthesis
of viral DNA is limited to a few copies of viral DNA per cell.
Each entering virion has the potential for producing one
provirus, with virion RNA being degraded by the RNase H
activity of reverse transcriptase during second-strand DNA
synthesis. Reverse transcription of progeny RNA requires
assembly of the RNA with capsid and polymerase proteins,
a process that occurs as virions bud from cells. With the
onset of virus production, reinfection (and concomitant
reverse transcription) is blocked by newly synthesized en-
velope glycoproteins competing for receptor activity (38).
In contrast to most type C virus infections, cultures of
human immunodeficiency virus type 1 (HIV-1)-infected T
cells tend to undergo the persistent synthesis of viral DNA,
with moderate to high levels of unintegrated viral DNA (20
to 100 copies per cell) being reported in recent infections and
lower levels of unintegrated DNA being present in chronic
infections (16, 21). Unintegrated DNA has also been re-
ported in lymph nodes from patients with acquired immuno-
deficiency syndrome (AIDS) (33).
Precedence for the accumulation of high levels of uninte-
grated retroviral DNA is found in certain type C virus- and
visna virus-infected cultures. In these, the accumulation of
DNA reflects reinfection due to the inefficient establishment
of envelope glycoprotein-mediated superinfection resistance
(12, 15, 39). In vitro infections that accumulate unintegrated
DNA are cytopathic (12, 15, 39). In vivo infections that
persistently produce unintegrated DNA cause disease, as
exemplified by avian leukosis virus-induced osteopetrosis
(28) and feline leukemia virus- and equine infectious anemia
virus-induced anemias (22, 27).
The goal of the current study was to determine whether
infection accounted for the production of high levels of
unintegrated DNA in HIV-1-infected T cells. C8166 cells
were chosen for the study because these cells are unusually
permissive for HIV-1 expression; most infected cells pro-
* Corresponding author.
duce viral structural proteins by 24 h after infection (35). Our
results clearly demonstrate that infection accounts for the
accumulation of high copy numbers of unintegrated viral
DNA in HIV-1-infected T cells.
MATERIALS AND METHODS
Cells. C8166 cells (30), H9 cells (25), and 8E5 cells (6) were
grown at densities of 1 x 106 to 2 x 106 cells per ml in RPMI
1640 supplemented with 10 to 15% fetal bovine serum,
penicillin, and streptomycin. C8166 cells are a line of human
T-cell leukemia virus type I-immortalized cord blood lym-
phocytes. The line does not express detectable levels of
human T-cell leukemia virus type I capsid protein but does
express the tax gene product (10). C8166 cells express
moderately high levels of CD4 (-80% of that observed on
mitogen stimulated CD4+ peripheral blood lymphocytes
[34]). H9 cells are a subline of HuT 78 cells (ATCC TIB161).
When obtained, the H9 culture contained cells with two
different densities of CD4 (34). This mixed population was
sorted for cells expressing the higher level of CD4 (a level
similar to that present on C8166 cells). The sorted cells have
maintained a uniform level of CD4 expression during further
culture. 8E5 cells are a line of A3.01 cells that contain a
single pol-defective provirus (contributed by T. Folks to the
AIDS Repository; no. 95). Only cultures in which >80% of
the 8E5 cells scored positive in an indirect immunofluores-
cence assay (IFA) (see below) were used in studies. South-
ern blot analyses of EcoRI-digested 8E5 DNA detected the
two expected junction fragments of viral and cellular DNA
(5.0 and 5.8 kilobases [kb]).
Plasmids. pHXB-2 was used as a source of HIV-1-IIIb
sequences (5). pS4 is a subclone of the 9.2-kb Sacl fragment
of pHXB-2 in the SacI site of Bluescript (Stratagene, La
Jolla, Calif.).
Antibody. A type-specific neutralizing serum for HIV-1-
IlIb, goat anti-PB1 serum (26) was obtained from Repligen,
Cambridge, Mass. leu3a, a mouse monoclonal antibody to
CD4 that blocks syncytium formation and infection (31), was
obtained from Becton Dickinson and Co. (Mountain View,
Calif.). Because preparations of leu3a contain azide, leu3a
was dialyzed against RPMI 1640 and sterilized by filtration
through a 0.45-,um-pore-size filter. The effective concentra-
tion of leu3a in dialyzed preparations was determined by
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testing twofold dilution series for the inhibition of syncytium
formation in HIV-1-IIIb-infected C8166 cells. Since experi-
ments with known amounts of leu3a had demonstrated
complete inhibition of syncytium formation with 120 but not
60 ng of leu3a per ml, a concentration of 120 ng/ml was
assigned to the highest dilution giving complete inhibition of
syncytium formation.
Virus production and IFA. Stocks of HIV-1-IIIb (8) were
produced by infecting exponentially growing H9 cells for 6 to
12 h in the presence of polybrene (10 ,ug/ml). Infected
cultures were seeded daily into fresh culture medium at 106
cells per ml. Starting at the third day after infection, culture
medium was saved and cultures were tested for the fraction
of cells expressing viral antigens by using an indirect IFA.
For the IFA, 2.5 x 105 cells were washed with phosphate-
buffered saline (PBS), suspended in 20 ,ul of PBS, and
allowed to settle on 10-well slides (Cell Line Associates,
Newfield, N.J.) by sequentially placing the 20-,ul droplet
over a series of wells. Settled cells were air dried, stored at
room temperature, and assayed within a few days for the
presence of HIV-1 antigens. HIV-1 antigens were detected
by fixing the air-dried cells for 5 to 10 min at room temper-
ature in methanol, washing with PBS, incubating for 30 min
at 37°C with an appropriately diluted heat-inactivated (57°C,
30 min) serum from an HIV-1-seropositive human, washing
three times with PBS, incubating for 30 min at 37°C with an
appropriately diluted fluorescein-treated goat anti-human
serum (H and L chain specific; Organon Teknika-Cappel,
Durham, N.C.), washing three times with PBS, and mount-
ing in 90% glycerin. Virus-positive and -negative cells were
counted with a fluorescence microscope with a reticle serv-
ing as a counting grid. Stained slides could be stored at 4°C
for several weeks. Titers (infectious units) of virus stocks
were determined by infecting C8166 cells with 1:2, 1:8, and
1:32 dilutions of the stock in the presence of Polybrene (2
,ug/ml). At 3 h after infection, leu3a (240 ng/ml) was added to
cultures. At 24 h after infection, cells were assayed for the
fraction expressing viral antigen by the IFA. Stock titers
were calculated as (percentage of virus-expressing cells) x
(concentration of C8166 cells at the time of infection) x (test
dilution). Titers obtained by this method agreed well with
those obtained by endpoint dilution on C8166 cells. The
highest-titered stocks (_ 106 infectious units per ml) were
obtained from cultures undergoing a spreading infection. All
multiplicities of infection represent infectious units per cell.
C8166 cell infection. Exponentially growing C8166 cells
were suspended at 106 cells per ml in a 1:2 dilution of a
high-titered stock of HIV-1 in the presence of Polybrene (10
,ug/ml). At 3 h after infection, cells were collected by
centrifugation and suspended in fresh culture medium in the
presence or absence of leu3a. Infections were monitored for
HIV-1-expressing cells by the IFA and for dead cells by the
failure to exclude trypan blue. Cultures grown in the absence
of leu3a formed syncytia.
Analyses for viral DNA. DNA was extracted from a
minimum of 5 x 106 cells by disrupting cells in 10 mM Tris
hydrochloride (pH 7.8)-10 mM EDTA-1% sodium dodecyl
sulfate, digesting with 2 p.g of proteinase K per ml at 37°C for
1 to 2 h, extracting with phenol and then chloroform, and
scooping out DNA that aggregated alter the addition of 0.1 M
NaCl and 2 volumes of 95% ethanol. Unintegrated viral
DNA was recovered as efficiently by this procedure as from
precipitates collected by centrifugation at 10,000 rpm for 20
min. Precipitated DNA was dissolved in 100 ,ul of T1E.1 (1
mM Tris hydrochloride [pH 7.8], 0.1 mM EDTA) for the
DNA from 107 cells. Extractions for unintegrated DNA were
performed by the method of Hirt (13). Hirt supernatant DNA
was also dissolved in 100 [L1 of T1E.1 for 107 initial cells.Quantitation of DNA sequences was done by alkali denatur-
ing approximately 4 p.g of test DNA in 0.3 M NaOH at 60 to
70°C for 1 h, neutralizing the denatured DNA by the addition
of 0.3 M HCl-0.2 M Tris hydrochloride (pH 8.0), and
collecting serial dilutions of the denatured DNA on duplicate
nylon filters in the presence of 1Ox SSC (lx SSC is 0.15 M
NaCl, 0.015 M sodium citrate). Serial dilutions (from 65 to 1
pg) of CsCl-purified pS4 DNA were denatured and collected
onto one of the filters to serve as a standard for HIV-1 DNA.
Serial dilutions (from 2 to 0.03 ,ug) of purified and denatured
human DNA were collected onto the second filter to serve as
a standard for human DNA. DNA from 8E5 cells was
included as a known positive in all tests. Uninfected cell
DNAs were included to determine background levels of
hybridization for the HIV-1 probe. DNAs were cross-linked
to filters by UV irradiation. Filters were blocked by prehy-
bridization with blotto (14) and hybridized in the presence of
6x SSC at 67°C with nick-translated pS4 DNA (to quantitate
HIV-1 sequences) or nick-translated human DNA (to quan-
titate human sequences). The amount of hybridized 32p_
labeled HIV-1 or human DNA was determined by counting
washed papers with a Betascope (Betagen, Waltham,
Mass.). Standard curves were constructed from data for
known amounts of HIV-1 or human DNA, and the amount of
HIV-1 or human DNA in test samples was determined from
the standard curve. The number of copies of pS4 per
picogram of DNA was calculated as (Avogadro's number)/
[(the sum of the number of nucleotides in the Sacl fragment
of HTLV-IIIb DNA and Bluescript) x (the average gram
molecular weight of one nucleotide) x (the conversion factor
for grams to picograms)] or (6.023 x 1023)/[(18.4 x 103 + 6.2
x 103)(330)(1 x 1012)]. Copies of HIV-1 DNA per cell were
then normalized by dividing the copies of HIV-1 DNA per
picogram of cell DNA in a test sample by the copies of
HIV-1 DNA per picogram of DNA in the 8E5 sample. Since
8E5 cells contain a single provirus, this calculation provides
an estimate of the copies per cell in the test sample. This
calculation assumes that C8166 and 8E5 cells have similar
amounts of DNA and normalizes the copy number of HIV-1
DNA in cultures containing syncytia to copies per 8E5 cell
equivalent of DNA.
DNA blot analyses. Southern blot analyses were done on
DNA fractionated by electrophoresis through 0.8 to 1.0%
agarose gels in the presence of a high-salt buffer (0.04 M Tris
hydrochloride, 0.001 M EDTA, 0.5 M sodium acetate [pH
7.9]). Gels were monitored for the efficiency of transfer by
ethidium bromide staining. Under our conditions of transfer,
the transfer of DNA fragments greater than 12 kb in size is
incomplete. Experiments in which 2 to 5 jig of undigested
DNA was mixed with up to 65 pg of linearized or covalently
closed circular HIV-1 plasmid DNA did not reveal trapping
of the plasmid DNA in high-molecular-weight DNA (data not
shown). Estimates of the proportions of HIV-1 DNA present
in integrated and unintegrated forms were done by using
betascope analyses. Since transfer of high-molecular-weight
DNA was incomplete, estimates for the amount of integrated
DNA are low. In these estimates, the background of hybrid-
ization observed for high-molecular-weight uninfected cell
DNA was subtracted from the band representing integrated
HIV-1 DNA.
RESULTS
leu3a retards infection. To identify conditions that pre-
vented HIV-1 infection, a type-specific neutralizing serum
VOL. 64, 1990
 at UNIV O
F M
ASS M






4838 ROBINSON AND ZINKUS
TABLE 1. leu3a retards the spread of HIV-1-IIIb
in C8166 culturesa
% HIV-1-IIIb-expressing cells
C8166 cells in leu3a after cocultivation for:
cocultivation (no.) (300 ng/ml)
Oh 28h 52h
Infected (105) + 10 20 79
Uninfected (106)
Infected (105) - 9 100
Uninfected (106)
a Exponentially growing C8166 cells were infected with 0.25 to 0.5 infec-
tious unit of HIV-1-IIIb per cell and grown in the presence of 300 ng of leu3a
per ml for 48 h. At 48 h, infected cells were cocultivated with uninfected
C8166 cells that had been grown in the presence or absence of leu3a for the
preceding 48 h. At the indicated times after cocultivation, HIV-1-expressing
cells were quantitated by the IFA.
and a receptor-blocking antibody were evaluated for their
ability to prevent HIV-1-IIIb infection of C8166 cells. The
neutralizing serum was a polyclonal goat antibody raised
against the PB1 peptide of the gpl20 envelope glycoprotein
of HIV-1-IIIb (26). The receptor-blocking antibody was
leu3a, a monoclonal antibody against CD4 that blocks infec-
tion and syncytium formation (31). The anti-PB1 serum did
not detectably reduce the titer of the -0.5 x 106 infectious
units present in the stock of HIV-1-IIIb. In contrast, 240 ng
of leu3a per ml completely blocked infection (data not
shown).
Since HIV-1 can undergo cell-to-cell transmission (11) and
C8166 cells grow in clumps, the ability of leu3a to block
HIV-1 spread within an infected culture was evaluated by
cocultivating 106 uninfected C8166 cells with 105 infected
cells in the presence and absence of leu3a (Table 1). At
various times after cocultivation, cultures were assayed for
the fraction of cells expressing HIV-1 antigens. Cocultiva-
tion in the absence of leu3a resulted in all of the cells
expressing HIV-1 antigens within 28 h. In cultures coculti-
vated in the presence of leu3a, a substantially slower spread
of the infection was observed; only 10% of the uninfected
cells became positive in the IFA by 28 h after infection.
Thus, the presence of 300 ng of leu3a per ml substantially
retarded the spread of HIV-1 in C8166 cell cultures.
HIV-1 DNA accumulation in the presence and absence of
leu3a. To assess the role of infection in the accumulation of
viral DNA in C8166 cells, cultures were infected with 0.25 to
0.5 infectious units of HIV-1-IIIb per cell. At 3 h after
infection, cells were collected and seeded in fresh medium in
the presence or absence of 300 ng of leu3a per ml. Samples
of these cultures were harvested at various times after
infection and analyzed for virus-expressing cells, dead cells,
and the amount and forms of viral DNA in cells (Table 2,
Fig. 1 and 2).
The presence of leu3a in cultures had little effect on the
amount of viral DNA at 12 h after infection but a substantial
and increasing effect on the accumulation of viral DNA at
later times after infection (Table 2). By 24 h, cultures grown
in the presence of leu3a contained <2 copies of viral DNA
per cell, whereas those grown in the absence of leu3a
contained -20 copies per cell. By 48 h after infection, cells
grown in the presence of leu3a contained -4 copies of viral
DNA, whereas cells grown in the absence of leu3a contained
-80. Thus, retardation of infection by leu3a resulted in a
20-fold reduction in the amount of viral DNA per cell.
Forms of viral DNA in infected cells. Undigested DNAs


























FIG. 1. Example of data used for estimation of copy numbers of
HIV-1 DNA per cell. (A) Copy number of HIV-1 sequences. The
standard (std) represents known copies of HIV-1 DNA x 106. (B)
Micrograms of cell DNA. The standard represents known quantities
(micrograms) of human DNA. Designations for test samples: st,
undiluted sample; 1:4, etc., diluted samples.
ern blots for the presence of integrated viral DNA (present in
high-molecular-weight chromosomal DNA), unintegrated
duplex linear DNA (present as a 9.6-kb species), and cova-
lently closed circular DNA (migrating as a doublet at -5 kb)
(Fig. 2A and B). In cultures grown in the presence of leu3a,
much of the viral DNA underwent integration (Fig. 2A). By
24 h, most of the 9.6-kb band present at 12 h appeared to
have integrated. At this time 20% of the cells expressed viral
antigens. As the first round or progeny virus spread to
uninfected cells, more 9.6-kb DNA appeared; this round of
9.6-kb DNA synthesis also appeared to integrate within 24 h
of its appearance.
In cultures grown in the absence of leu3a (Fig. 2A and B),
patterns of relative band intensities were again consistent
with the 9.6-kb linear duplex of viral DNA integrating within
24 h of its appearance (see relative intensities of the 9.6-kb
band at 24 h after infection and the high-molecular-weight
band at 48 h after infection in Fig. 2A). By 48 h, the most
abundant form of viral DNA was a broad smear of viral
sequences (most clearly seen in Fig. 2B). The appearance of
this smear was not accompanied by obvious degradation of
high-molecular-weight chromosomal DNA (Fig. 2B).
To further analyze the forms of unintegrated viral DNA,
DNA harvested at various times after infection was digested
with EcoRI and analyzed on Southern blots for fragments
characteristic of linear and covalently closed circular viral
DNA (Fig. 2C). The EcoRI-digested DNA clearly demon-
strated the appearance of fragments unique to unintegrated
linear DNA (4.6 and 3.9 kb) before the appearance of bands
unique to the presumed one-long-terminal-repeat (7.9 kb)
and two-long-terminal-repeat forms (8.5 kb) of covalently
closed circular DNA. Fragments representing closed circu-
lar DNA always migrated as a doublet, and the more rapidly
migrating form of the doublet (presumed one-long-terminal-
repeat form) was present at higher levels than the more
slowly migrating form (most clearly exhibited in Fig. 2A and
C). Analyses of EcoRI fragments of Hirt supernatant DNA
from cultures grown in the absence of leu3a revealed bands
representing the linear and closed circular forms, the 1.1-kb
fragment common to all forms, and a smear of fragments
migrating as approximately 3 kb or shorter linear species
(presumably representing the smear observed in undigested
DNA).
DISCUSSION
Accumulation of HIV-1 DNA. Our results demonstrate that
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FIG. 2. Forms of HIV-1-IIIb DNA in C8166 cells at various times after infection. (A and B) Blot analyses of undigested total cell DNA.
Panels A and B present independent blots of the same 48-h samples. (C) Blot analysis of EcoRI-digested total cell DNA (+leu3a samples) and
Hirt supernatant DNA (-leu3a sample). The schematic diagram shows the positions of EcoRI sites (R) in HIV-1-IIIb. DNA blots were
hybridized with nick-translated pS4 sequences. Numbers at the tops of lanes indicate hours after infection. Abbreviations: HMW,
high-molecular-weight chromosomal DNA; CCC, covalently closed circular DNA. The sizes of fragments are indicated in kilobases.
Designations below data indicate whether DNAs were from cultures grown in the presence or absence of leu3a. Ethidium indicates an
ethidium bromide-stained gel. A lane containing HindIII marker fragments is presented for the ethidium bromide-stained gel.
infection events (Table 2). This was demonstrated by infect-
ing cultures and then growing the infected cultures in the
presence or absence of an antibody to CD4 that blocks
HIV-1 infection (Table 1). During the first 48 h of infection,
cultures grown in the presence of the antibody accumulated
-4 copies of HIV-1 DNA per cell, whereas those grown in
the absence of antibody accumulated -80 copies of viral
DNA per cell (Table 2). In the latter cultures, most of the 80
copies were incomplete viral sequences that migrated as a
broad smear (Fig. 2B).
The accumulation of high copy numbers of HIV-1 DNA in
C8166 cultures correlated with the appearance of virus-
expressing cells. Thus, the production of high copy numbers
of viral DNA was most likely due to progeny virus infecting
cells that had not established superinfection resistance.
HIV-1 envelope glycoproteins are able to establish superin-
fection resistance (4, 36). However, the time between the
initiation of an infection and the establishment of superin-
fection resistance may be prolonged by differential gene
expression (16) and the dependence of HIV-1 envelope
glycoprotein synthesis on the expression of tat and rev
proteins (17, 18; for a review, see reference 3). Electron
micrographs reveal HIV-1-producing cells releasing high
levels of budding virions (24, 36). Thus, high levels of virion
production coupled with relatively slow establishment of
superinfection resistance could contribute to the copy num-
bers of viral DNA present in cultures grown in the absence
of leu3a.
TABLE 2. HIV-1-IIIb DNA copies per cella
Treatmentb h after % IFA` % Dead DNA copies/celld % Integrated PV/celfinfection cells cells' xt1Ep DNA e
With leu3a 12 <1 1 2.6, 1 19 0.3
24 20 1 1.6, 1.5 37 0.6
48 70 2 5, 3.5 5.6, 2 34 1.4
72 90 10 6, 4.5 48 2.5
96 95 50 7.3, 4 39 2.2
Without leu3a 12 <1 1 2.3, 1 <10 <0.2
24 (Syncytia) 24, 15 15 3.0
48 (Syncytia) 88, 58 75, 100 15 12.0
a For experimental details, see the text.
b C8166 cells infected with HIV-1-IIIb were tested with and without leu3a.
Dead cells were not quantitated in cultures undergoing syncytium formation.d Copy numbers for cultures containing syncytia are normalized for single-cell equivalents of DNA.
e Percentage of integrated viral DNA was estimated by dividing counts hybridized to high-molecular-weight DNA by counts hybridized to all forms of viral
DNA. These represent minimum estimates, because transfer of high-molecular-weight DNA was incomplete.
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Defective reverse-transcript-forming units could also have
contributed to the accumulation of high copy numbers of
viral DNA. The experiments reported in Table 2 were
initiated at a multiplicity of infection of 0.25 to 0.5 infectious
unit per cell. Infection at this multiplicity resulted in the
production of just under two reverse transcripts per cell by
12 h after infection (Table 2). Since there is little virus
production during the first 12 h of infection, our stocks of
HIV-1-IIIb would appear to contain several reverse-tran-
script-forming units for each infectious unit. Most of the
defective reverse transcripts did not score in the IFA (see
Materials and Methods). Thus, most of these may not have
had the potential to express the viral envelope glycoproteins
that establish superinfection resistance. There is much pre-
cedence for the packaging of defective virus by retroviruses
as well as for the presence of more defective than nondefec-
tive virus in HIV-1 infections (for the frequency of defective
tat genes in patient samples, see reference 20).
Forms of HIV-1 DNA. Four forms of viral DNA were
observed: high-molecular-weight (integrated DNA), a 9.6-kb
linear duplex, an -5-kb doublet representing covalently
closed circular DNA, and a broad smear of incomplete viral
sequences. In cultures grown in the presence or absence of
leu3a, the relative hybridization intensities of the 9.6-kb
linear duplex and high-molecular-weight sequences were
consistent with the 9.6-kb species being the precursor to
integrated DNA. Irrespective of whether a culture was
grown in the presence or absence of leu3a, the 9.6-kb species
appeared to undergo integration within 24 h of its appear-
ance. The broad smear of viral sequences was only detected
in cultures undergoing active reinfection. This smear could
represent nascent transcripts, since it appeared at at time
when the culture was producing high copy numbers of HIV-1
DNA and since smears of viral DNA occur in cultures
undergoing active synthesis of hepatitis B virus DNA (Table
2) (19). Alternatively, this smear could represent degradation
of DNA as cultures underwent cell death (note that the
smear includes sequences longer than full-length viral
DNA), defective-deleted forms of viral DNA, or a combina-
tion of the above possibilities. The appearance of the smear
did not accompany widespread degradation of chromosomal
DNA, since ethidium bromide stains of gels containing
undigested DNA did not reveal smears of chromosomal
DNA or nucleosome ladders (Fig. 2B).
Generality of results. Our experiments clearly demonstrate
that T cells accumulate unintegrated HIV-1 DNA as a result
of multiple virions entering cells and not by intracellular
reverse transcription of newly synthesized HIV-1 RNA.
This result is consistent with polymerase chain reaction
analyses of the copy number of HIV-1 DNA in peripheral
blood lymphocytes from patients with AIDS. These tests
suggest that the rare infected T cells (-1% of the CD4+ cells)
contain a single copy of viral DNA (32). This single copy of
DNA presumably arises from reverse transcription of the
RNA of an infecting virus.
The mechanism for DNA accumulation in HIV-1-infected
T cells may not necessarily represent the sole mechanism for
DNA accumulation in other cell types. In visna virus-
infected sheep, -1% of the choroid plexus cells and mono-
cytes contain multiple copies of viral DNA (1, 23). The
presence of multiple reverse transcripts in the infrequent
positive cell suggests that a single infectious event can
generate multiple copies of viral DNA. This may correlate
with whether virions undergo intracellular assembly. Elec-
tron micrographs of HIV-1-infected monocytes or macro-
phages reveal intracellular assembly, with the assembling
virus budding into cytoplasmic vacuoles (9). Thus, an in-
fected monocyte or macrophage may have the potential to
reverse transcribe newly synthesized HIV-1 RNA. In con-
trast, electron micrographs of HIV-1-infected T cells do not
reveal intracellular assembly and budding of virus (9, 24).
This would be consistent with the data in Table 2, which
indicate that newly synthesized HIV-1 RNA does not un-
dergo reverse transcription in T cells.
ACKNOWLEDGMENTS
We thank D. W. Brown, C. A. Holland, and C. Mulder for critical
comments on the manuscript. We are indebted to R. C. Gallo and
co-workers for the provision of HIV-1-IIIb, C8166 and H9 cells, and
pHXB-2, to the AIDS repository for 8E5 cells, and to Becton
Dickinson for facilitating our purchase of volume quantities of leu3a.
This research was supported by Public Health Service award Al
24474 from the National Institutes of Health.
LITERATURE CITED
1. Brahic, M., L. Stowring, P. Ventura, and A. T. Haase. 1981.
Gene expression visna virus infection in sheep. Nature (Lon-
don) 292:240-242.
2. Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop.
1989. Retroviral integration: structure of the initial covalent
product and its precursor, and a role for the viral INtegrase
protein. Proc. Natl. Acad. Sci. USA 86:2525-2529.
3. Cullen, B. R., and W. C. Greene. 1989. Regulatory pathways
governing HIV-1 replication. Cell 58:423-426.
4. Dalgliesh, A., P. Beverley, P. Clapham, D. Crawford, M.
Greaves, and R. Weiss. 1984. The CD4 (T4) antigen is an
essential component of the receptor for the AIDS retrovirus.
Nature (London) 312:763-766.
5. Fisher, A. G., E. Collatti, L. Ratner, R. C. Galo, and F.
Wong-Staal. 1985. A molecular clone of HTLV-III with biolog-
ical activity. Nature (London) 316:262-265.
6. Folks, T. M., D. Powell, M. Lightfoote, S. Koenig, A. S. Fauci, S.
Benn, A. Rabson, D. Daugherty, H. E. Gendelman, M. D.
Hoggan, S. Venkatesan, and M. A. Martin. 1986. Biological and
biochemical characterization of a cloned Leu-3- cell surviving
infection with the acquired immune deficiency syndrome retro-
virus. J. Exp. Med. 164:280-290.
7. Fujiwara, T., and K. Mizuuchi. 1988. Retroviral DNA integra-
tion: structure of an integration intermediate. Cell 54:497-504.
8. Gallo, R. C., S. Z. Salahuddin, M. Popovic, G. M. Shearer, M.
Kaplan, B. F. Haynes, T. J. Palker, R. Redfield, J. Oleske, B.
Safai, G. White, P. Foster, and P. D. Markham. 1984. Frequent
detection and isolation of cytopathic retroviruses (HTLV-III)
from patients with AIDS and at risk for AIDS. Science 224:500-
503.
9. Gendelman, H. E., J. M. Orenstein, M. A. Martin, C. Ferrura,
R. Mitra, T. Phipps, L. A. Wahl, H. C. Lane, A. S. Fauci, D. S.
Burke, D. Skillman, and M. S. Meltzer. 1988. Efficient isolation
and propagation of human immunodeficiency virus in recombi-
nant colony stimulating factor 1-treated monocytes. J. Exp.
Med. 167:1428-1441.
10. Giam, C. Z., M. Nerenberg, G. Khoury, and G. Jay. 1986.
Expression of the complete human T-cell leukemia virus type I
pX coding sequence as a functional protein in Escherichia coli.
Proc. Natl. Acad. Sci. USA 83:7192-7196.
11. Gupta, P., R. Balachandran, M. Ho, A. Enrico, and C. Rinaldo.
1989. Cell to cell transmission of human immunodeficiency virus
type I in the presence of azidothymidine and neutralizing
antibody. J. Virol. 63:2361-2365.
12. Haase, A. T., L. Stowring, J. D. Harris, B. Traynor, P. Ventura,
R. Peluso, and M. Brahic. 1982. Visna DNA synthesis and the
tempo of infection in vitro. Virology 119:399-410.
13. Hirt, B. 1967. Selective extraction of polyoma DNA from
infected mouse cell cultures. J. Mol. Biol. 26:365-369.
14. Johnson, D. A., J. W. Gautsch, J. R. Sportsman, and J. H.
Elder. 1984. Improved technique utilizing non fat dry milk for
analysis of proteins and nucleic acids transferred to nitrocellu-
J. VIROL.
 at UNIV O
F M
ASS M






HIV-1 DNA SYNTHESIS IN T CELLS 4841
lose. Gene Anal. Tech. 1:3-8.
15. Keshet, E., and H. M. Temin. 1979. Cell killing by spleen
necrosis virus is correlated with a transient accumulation of
spleen necrosis virus DNA. J. Virol. 31:376-388.
16. Kim, S., R. Byrn, J. Groopman, and D. Baltimore. 1989.
Temporal aspects of DNA and RNA synthesis during human
immunodeficiency virus infection: Evidence for differential gene
expression. J. Virol. 63:3708-3713.
17. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 Tat
protein increases transcriptional initiation and stabilizes elonga-
tion. Cell 59:283-292.
18. Malim, H. M., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R.
Cullen. 1989. The HIV-1 rev trans-activator acts through a
structured target sequence to activate nuclear export of un-
spliced viral mRNA. Nature (London) 338:254-257.
19. Mason, W. S., C. Aldrich, J. Summers, and J. M. Taylor. 1982.
Asymmetric replication of duck hepatitis B virus DNA in liver
cells: free minus-strand DNA. Proc. Natl. Acad. Sci. USA
79:3997-4001.
20. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwik, J.
Sninsky, L. Morfeldt-Manson, B. Asjo, and S. Wain-Hobson.
1989. Temporal fluctuations in HIV quasispecies in vivo are not
reflected by sequential HIV isolations. Cell 58:901-910.
21. Muesing, M. A., D. H. Smith, C. D. Cabradilla, C. V. Benton,
L. A. Lasky, and D. J. Capon. 1985. Nucleic acid structure and
expression of the human AIDS/lympadenopathy retrovirus.
Nature (London) 313:450-458.
22. Mullins, J. I., C. S. Chen, and E. A. Hoover. 1986. Disease-
specific and tissue-specific production of unintegrated feline
leukemia virus variant DNA in feline AIDS. Nature (London)
319:333-336.
23. Peluso, R., A. Haase, L. Stowring, M. Edwards, and P. Ventura.
1985. A trojan horse mechanism for the spread of visna virus in
monocytes. Virology 147:231-236.
24. Poli, G., J. M. Orenstein, A. Kinter, T. M. Folks, and A. S.
Fauci. 1989. Interferon-a but not AZT supresses HIV expres-
sion in chronically infected cell lines. Science 244:575-577.
25. Popovic, M., M. G. Sarngadharan, E. Read, and R. C. Gallo.
1984. Detection, isolation and continuous production of cyto-
pathic retroviruses (HTLV-III) from patients with AIDS and
Pre-AIDS. Science 224:497-500.
26. Putney, S. D., T. J. Matthews, W. G. Robey, D. Lynn, M.
Buroff, W. T. Mueller, A. J. Langlois, J. Ghrayeb, S. R.
Petteway, Jr., K. J. Weinhold, P. J. Fischinger, F. Wong-Staal,
R. C. Gallo, and D. P. Bolognesi. 1986. HTLV-III/LAV-neutral-
izing antibodies to an E. coli-produced fragment of the virus
envelope. Science 234:1392-1395.
27. Rice, N. R., A. S. Lequarre, J. W. Casey, S. Lahn, R. M.
Stephens, and J. Edwards. 1989. Viral DNA in horses infected
with equine infectious anemia virus. J. Virol. 63:5194-5200.
28. Robinson, H. L., and B. D. Miles. 1985. Avian leukosis virus-
induced osteopetrosis is associated with the persistent synthesis
of viral DNA. Virology 141:130-143.
29. Roth, M. J., P. L. Schwartzberg, and S. P. Goff. 1989. Structure
of the termini of DNA intermediates in the integration of
retroviral DNA: dependence on IN function and terminal DNA
sequence. Cell 58:47-54.
30. Salahuddin, S. Z., P. D. Markham, F. Wong-Staal, G. Franchini,
V. S. Kalyanaraman, and R. C. Gallo. 1983. Restricted expres-
sion of human T-cell leukemia-lymphoma virus (HTLV) in
transformed human umbilical cord blood lymphocytes. Virology
129:51-64.
31. Sattentau, Q. J., A. G. Dalgleish, R. A. Weiss, and P. C. L.
Beverley. 1986. Epitopes of the CD4 antigen and HIV infection.
Science 234:1120-1123.
32. Schnittman, S. M., M. C. Psallidopoulos, H. C. Lane, L.
Thompson, M. Baseler, F. Massari, C. H. Fox, N. P. Salzman,
and A. S. Fauci. 1989. The reservoir for HIV-1 in human
peripheral blood is a T cell that maintains expression of CD4.
Science 245:305-308.
33. Shaw, G. M., B. H. Hahn, S. K. Arya, J. E. Groopman, R. C.
Gallo, and F. Wong-Staal. 1984. Molecular characterization of
human T-cell leukemia (lymphotropic) virus type III in the
acquired immune deficiency syndrome. Science 226:1165-1171.
34. Somasundaran, M., and H. L. Robinson. 1987. A major mecha-
nism of human immunodeficiency virus-induced cell killing does
not involve cell fusion. J. Virol. 61:3114-3119.
35. Somasundaran, M., and H. L. Robinson. 1988. Unexpectedly
high levels of HIV-1 RNA and protein synthesis in a cytocidal
infection. Science 242:1554-1557. (Correction: Science 247:
1531, 1990.)
36. Stevenson, M., C. Meier, A. M. Mann, N. Chapman, and A.
Wasiak. 1988. Envelope glycoprotein of HIV induces interfer-
ence and cytolysis resistance in CD4+ cells: mechanism for
persistance in AIDS. Cell 53:483-496.
37. Varmus, H., and R. Swanstrom. 1984. Replication of retrovi-
ruses, p. 369-512. In R. Weiss, N. Teich, H. Varmus, and J.
Coffin (ed.), RNA tumor viruses, 2nd ed. Cold Spring Harbor
Laboratory, Cold Spring Harbor, N.Y.
38. Vogt, P. K., and R. Ishizaki. 1966. Patterns of viral interference
in the avian leukosis and sarcoma complex. Virology 30:368-
374.
39. Weller, S. K., A. E. Joy, and H. M. Temen. 1980. Correlation
between cell killing and massive second round superinfection by
members of some subgroups of avian leukosis virus. J. Virol.
33:494-506.
VOL. 64, 1990
 at UNIV O
F M
ASS M
ED SCH on August 4, 2008 
jvi.asm.org
D
ow
nloaded from
 
